focus -WSS

focus

author：comprehensive 2025-09-28 18:47:41 - browse：2

A crowd of miniature figurines facing towards an hourglass. -- cancer coverage from STAT — Adobe

It’s no secret that a lucky few seem to glide into old age, the years settling gracefully on their bodies, while others appear to have been dragged through time tied to a metaphorical garbage truck. Biologists have been developing numerous ways to measure the rate an individual ages — often called an accelerated or decelerated “biological age” — and trying to translate it into a heightened or reduced risk of the morbidity and mortality that comes with aging.

There’s been a proliferation of various biological aging clocks, mathematical models that look at things like genetic markers or proteins in your body to make some estimation of an individual’s biological age. Research interest in using these clocks has exploded. In the last five years, thousands of papers on or incorporating the clocks have been published. The paper describing one popular biological aging clock, PhenoAge, has over 1,800 citations alone. One recent study suggested that a reason cancer incidence is increasing among younger adults may be accelerated aging, based on this particular clock.

But as scientists use these clocks to associate biological age with specific health risks, like cancer or dementia, and numerous companies eagerly offer biological age measurements in exchange for hundreds of bucks, it may be worth noting that experts don’t agree on what “biological age” actually is.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Prosecutors say FTX founder Sam Bankman

hotspot

WSS

FDA warns medical device makers about rise in fabricated data

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

In 'major milestone,' FDA approves first cell therapy for solid tumors

New CMS data security rules will hurt Medicare, Medicaid research

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

New CMS data security rules will hurt Medicare, Medicaid research

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

Malaria cases in Florida and Texas: Here’s what you need to know

A new drug could help frostbite victims avoid its ravages

Moonlake's readout produced a cash windfall. Risks remain

Medicare Advantage enrollment hits roughly 33.4 million

United colonoscopy coverage change 'may cost lives,' doctors say

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Duchenne breakthrough therapy leaves behind pioneering families

A new drug could help frostbite victims avoid its ravages

How to save PrEP access — and even expand it

How Brent Saunders' Allergan experiment failed

explore

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Weight loss drugs aren’t covered by Obamacare. That may change

EMA weighs against approval for Mirati's lung cancer drug

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

New chief aims to remake Sanofi Genzyme

hotspot

knowledge

hotspot

focus